Vimarsana
Biggest News Aggregation in the World

Page 30 - Peter Sands News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Sands. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Sands Today - Breaking & Trending Today

Tinubu administration to prioritise domestic health financing, others - Vimarsana News

Tinubu administration to prioritise domestic health financing, others

Mr Shettima says the administration is committed to changing the narrative of inclusive growth, of a Nigeria where every black man will be proud.

We will increase health financing, promote industrialisation - Vimarsana News

We will increase health financing, promote industrialisation

Mr Shettima said the administration of President Tinubu is committed to changing the narrative of inclusive growth, “of a Nigeria where every black man will be proud of.”

Tinubu'll prioritise domestic health financing for better outcomes — Shettima - Vimarsana News

Tinubu'll prioritise domestic health financing for better outcomes — Shettima

Vice President Kashim Shettima on Tuesday said the Tinubu administration has its eyes locked on domestic routes to financing the health needs of Nigerians.

Global Fund secures deal to slash HIV treatment price - Vimarsana News

Global Fund secures deal to slash HIV treatment price

The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives."Reduced pricing for TLD means governments and other implementers of Global Fund grants can expand treatment programmes and invest more in prevention, saving more lives and reducing new infections."

Source: yahoo.com
Global Fund Agreements Substantially Reduce the Price of First-line HIV Treatment to Below US$45 a Year - Vimarsana News

Global Fund Agreements Substantially Reduce the Price of First-line HIV Treatment to Below US$45 a Year

Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), a first-line HIV treatment for under US$45 per person, per year for the first time. This improved pricing – a 25% reduction – will allow governments in resource-limited settings to expand access to critical HIV services.